Back to search

Article

Improving the efficiency of liver targeting rAAV-mediated homologous recombination using ribonucleotide reductase inhibitors

2020-12-10

Abstract excerpt

<title>Abstract</title> <p>Recombinant adeno-associated viral (rAAV) vectors continue to gain popularity for <italic>in vivo</italic> therapeutic gene delivery. Homologous recombination-based gene therapy using rAAV (AAV-HR) without nucleases has several advantages over classical gene therapy, especially when targeting the liver in neonatal/pediatric populations due to its potential for permanent sustained transg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b120fcd0-849b-5c17-94e2-0d94409ad71b
DOI
10.21203/rs.3.rs-106148/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improving the efficiency of liver targeting rAAV-mediated homologous recombination using ribonucleotide reductase inhibitorsDOI 10.21203/rs.3.rs-106148/v1
Select a neighboring publication to make it the new centre.